Skip to main content

Christopher Primiano

Equibles does not estimate personal net worth.

Get an email with a short summary when Karyopharm Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get KPTI alerts

About Christopher Primiano

Christopher Primiano is recorded as General Counsel at Karyopharm Therapeutics Inc. (KPTI). The proxy statement of Karyopharm Therapeutics Inc. reports total compensation of $1,623,347 for Christopher Primiano in fiscal 2019, including a base salary of $418,200. Disclosed compensation is on record for 2 fiscal years. Karyopharm Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Karyopharm Therapeutics Inc. includes Richard Paulson (CEO and Board Member), Senior Clinical (CEO), Michael Mano (General Counsel) and 7 others.

Affiliation history

Company network

Leadership on record at Karyopharm Therapeutics Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2019 Karyopharm Therapeutics Inc. (KPTI) $418,200 $1,623,347
2018 Karyopharm Therapeutics Inc. (KPTI) $404,000 $1,522,593

Recent activity

No call appearances or filed executive changes recorded yet.